AYBARION TRADEEU trade movers · 2026-02 · chapter 30
EU trade movers: February 2026, Pharmaceutical products
The largest month on month and year on year changes in the trade of each EU member state with each partner country, per HS4 product in chapter 30. Flows of at least EUR 5 million in February 2026; percent lists need at least EUR 1 million in the comparison month. Every figure carries its Eurostat record ID.
January 2026 · March 2026 · All chapters, February 2026 · Atom feed
Largest month on month changes, EUR
| # | Flow | Product | February 2026 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Germany exports to United States | 3002 Human blood | EUR 1.4 billion | EUR 2.2 billion 2026-01 | −EUR 781.4 million | −35.2% | DS-045409:DE:US:3002:2:2026-02 DS-045409:DE:US:3002:2:2026-01 |
| 2 | Slovenia exports to Switzerland | 3004 Medicaments | EUR 1.5 billion | EUR 831.2 million 2026-01 | +EUR 689.2 million | +82.9% | DS-045409:SI:CH:3004:2:2026-02 DS-045409:SI:CH:3004:2:2026-01 |
| 3 | Denmark exports to Netherlands | 3002 Human blood | EUR 566.6 million | EUR 23.9 million 2026-01 | +EUR 542.7 million | +2,269.4% | DS-045409:DK:NL:3002:2:2026-02 DS-045409:DK:NL:3002:2:2026-01 |
| 4 | Netherlands imports from Denmark | 3002 Human blood | EUR 553.1 million | EUR 28.5 million 2026-01 | +EUR 524.6 million | +1,843.5% | DS-045409:NL:DK:3002:1:2026-02 DS-045409:NL:DK:3002:1:2026-01 |
| 5 | Italy imports from China | 3004 Medicaments | EUR 655.8 million | EUR 154.9 million 2026-01 | +EUR 500.9 million | +323.4% | DS-045409:IT:CN:3004:1:2026-02 DS-045409:IT:CN:3004:1:2026-01 |
| 6 | Italy exports to United States | 3004 Medicaments | EUR 810.2 million | EUR 1.2 billion 2026-01 | −EUR 355.3 million | −30.5% | DS-045409:IT:US:3004:2:2026-02 DS-045409:IT:US:3004:2:2026-01 |
| 7 | Ireland exports to United States | 3003 Medicaments | EUR 345.6 million | EUR 21.2 million 2026-01 | +EUR 324.4 million | +1,529.7% | DS-045409:IE:US:3003:2:2026-02 DS-045409:IE:US:3003:2:2026-01 |
| 8 | Italy exports to United States | 3002 Human blood | EUR 726.9 million | EUR 418.9 million 2026-01 | +EUR 308.0 million | +73.5% | DS-045409:IT:US:3002:2:2026-02 DS-045409:IT:US:3002:2:2026-01 |
| 9 | Italy exports to Switzerland | 3004 Medicaments | EUR 660.8 million | EUR 363.3 million 2026-01 | +EUR 297.5 million | +81.9% | DS-045409:IT:CH:3004:2:2026-02 DS-045409:IT:CH:3004:2:2026-01 |
| 10 | Germany exports to Switzerland | 3004 Medicaments | EUR 523.8 million | EUR 237.2 million 2026-01 | +EUR 286.6 million | +120.8% | DS-045409:DE:CH:3004:2:2026-02 DS-045409:DE:CH:3004:2:2026-01 |
| 11 | Germany exports to United States | 3004 Medicaments | EUR 783.1 million | EUR 496.6 million 2026-01 | +EUR 286.5 million | +57.7% | DS-045409:DE:US:3004:2:2026-02 DS-045409:DE:US:3004:2:2026-01 |
| 12 | Netherlands imports from Ireland | 3002 Human blood | EUR 1.3 billion | EUR 1.1 billion 2026-01 | +EUR 255.7 million | +23.9% | DS-045409:NL:IE:3002:1:2026-02 DS-045409:NL:IE:3002:1:2026-01 |
| 13 | Belgium imports from France | 3004 Medicaments | EUR 377.9 million | EUR 124.3 million 2026-01 | +EUR 253.6 million | +204.0% | DS-045409:BE:FR:3004:1:2026-02 DS-045409:BE:FR:3004:1:2026-01 |
| 14 | Ireland exports to Netherlands | 3002 Human blood | EUR 1.3 billion | EUR 1.0 billion 2026-01 | +EUR 212.5 million | +20.5% | DS-045409:IE:NL:3002:2:2026-02 DS-045409:IE:NL:3002:2:2026-01 |
| 15 | Ireland exports to United States | 3004 Medicaments | EUR 517.1 million | EUR 720.6 million 2026-01 | −EUR 203.5 million | −28.2% | DS-045409:IE:US:3004:2:2026-02 DS-045409:IE:US:3004:2:2026-01 |
Largest month on month changes, percent
| # | Flow | Product | February 2026 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Denmark exports to Netherlands | 3002 Human blood | EUR 566.6 million | EUR 23.9 million 2026-01 | +EUR 542.7 million | +2,269.4% | DS-045409:DK:NL:3002:2:2026-02 DS-045409:DK:NL:3002:2:2026-01 |
| 2 | Netherlands imports from Denmark | 3002 Human blood | EUR 553.1 million | EUR 28.5 million 2026-01 | +EUR 524.6 million | +1,843.5% | DS-045409:NL:DK:3002:1:2026-02 DS-045409:NL:DK:3002:1:2026-01 |
| 3 | Austria imports from Singapore | 3002 Human blood | EUR 20.4 million | EUR 1.1 million 2026-01 | +EUR 19.3 million | +1,737.3% | DS-045409:AT:SG:3002:1:2026-02 DS-045409:AT:SG:3002:1:2026-01 |
| 4 | Austria exports to China | 3004 Medicaments | EUR 45.7 million | EUR 2.7 million 2026-01 | +EUR 43.0 million | +1,618.8% | DS-045409:AT:CN:3004:2:2026-02 DS-045409:AT:CN:3004:2:2026-01 |
| 5 | Spain exports to United States | 3006 Pharmaceutical goods | EUR 23.3 million | EUR 1.4 million 2026-01 | +EUR 21.8 million | +1,532.1% | DS-045409:ES:US:3006:2:2026-02 DS-045409:ES:US:3006:2:2026-01 |
| 6 | Ireland exports to United States | 3003 Medicaments | EUR 345.6 million | EUR 21.2 million 2026-01 | +EUR 324.4 million | +1,529.7% | DS-045409:IE:US:3003:2:2026-02 DS-045409:IE:US:3003:2:2026-01 |
| 7 | Sweden exports to Canada | 3004 Medicaments | EUR 38.4 million | EUR 3.3 million 2026-01 | +EUR 35.1 million | +1,059.4% | DS-045409:SE:CA:3004:2:2026-02 DS-045409:SE:CA:3004:2:2026-01 |
| 8 | France imports from South Korea | 3002 Human blood | EUR 24.0 million | EUR 2.3 million 2026-01 | +EUR 21.7 million | +947.9% | DS-045409:FR:KR:3002:1:2026-02 DS-045409:FR:KR:3002:1:2026-01 |
| 9 | Germany exports to Iran | 3004 Medicaments | EUR 16.2 million | EUR 1.6 million 2026-01 | +EUR 14.6 million | +899.3% | DS-045409:DE:IR:3004:2:2026-02 DS-045409:DE:IR:3004:2:2026-01 |
| 10 | Netherlands imports from Hungary | 3002 Human blood | EUR 11.8 million | EUR 1.3 million 2026-01 | +EUR 10.6 million | +826.8% | DS-045409:NL:HU:3002:1:2026-02 DS-045409:NL:HU:3002:1:2026-01 |
| 11 | Italy exports to Australia | 3002 Human blood | EUR 40.9 million | EUR 4.6 million 2026-01 | +EUR 36.3 million | +784.7% | DS-045409:IT:AU:3002:2:2026-02 DS-045409:IT:AU:3002:2:2026-01 |
| 12 | Poland exports to Brazil | 3002 Human blood | EUR 20.4 million | EUR 2.6 million 2026-01 | +EUR 17.8 million | +678.3% | DS-045409:PL:BR:3002:2:2026-02 DS-045409:PL:BR:3002:2:2026-01 |
| 13 | Netherlands imports from Italy | 3006 Pharmaceutical goods | EUR 11.0 million | EUR 1.5 million 2026-01 | +EUR 9.6 million | +649.1% | DS-045409:NL:IT:3006:1:2026-02 DS-045409:NL:IT:3006:1:2026-01 |
| 14 | Sweden exports to Taiwan | 3004 Medicaments | EUR 23.1 million | EUR 3.1 million 2026-01 | +EUR 20.0 million | +646.0% | DS-045409:SE:TW:3004:2:2026-02 DS-045409:SE:TW:3004:2:2026-01 |
| 15 | Portugal exports to Ireland | 3004 Medicaments | EUR 9.1 million | EUR 1.2 million 2026-01 | +EUR 7.8 million | +635.8% | DS-045409:PT:IE:3004:2:2026-02 DS-045409:PT:IE:3004:2:2026-01 |
Largest year on year changes, EUR
| # | Flow | Product | February 2026 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Germany imports from Ireland | 3004 Medicaments | EUR 266.7 million | EUR 1.0 billion 2025-02 | −EUR 777.6 million | −74.5% | DS-045409:DE:IE:3004:1:2026-02 DS-045409:DE:IE:3004:1:2025-02 |
| 2 | Ireland exports to Germany | 3004 Medicaments | EUR 254.9 million | EUR 1.0 billion 2025-02 | −EUR 753.6 million | −74.7% | DS-045409:IE:DE:3004:2:2026-02 DS-045409:IE:DE:3004:2:2025-02 |
| 3 | Ireland imports from Germany | 3004 Medicaments | EUR 46.2 million | EUR 767.9 million 2025-02 | −EUR 721.7 million | −94.0% | DS-045409:IE:DE:3004:1:2026-02 DS-045409:IE:DE:3004:1:2025-02 |
| 4 | Italy imports from China | 3004 Medicaments | EUR 655.8 million | EUR 5.7 million 2025-02 | +EUR 650.0 million | +11,332.3% | DS-045409:IT:CN:3004:1:2026-02 DS-045409:IT:CN:3004:1:2025-02 |
| 5 | Ireland imports from Italy | 3004 Medicaments | EUR 587.3 million | EUR 21.5 million 2025-02 | +EUR 565.8 million | +2,633.1% | DS-045409:IE:IT:3004:1:2026-02 DS-045409:IE:IT:3004:1:2025-02 |
| 6 | Denmark exports to Netherlands | 3002 Human blood | EUR 566.6 million | EUR 3.6 million 2025-02 | +EUR 563.0 million | +15,601.2% | DS-045409:DK:NL:3002:2:2026-02 DS-045409:DK:NL:3002:2:2025-02 |
| 7 | Netherlands imports from Denmark | 3002 Human blood | EUR 553.1 million | EUR 8.4 million 2025-02 | +EUR 544.7 million | +6,512.6% | DS-045409:NL:DK:3002:1:2026-02 DS-045409:NL:DK:3002:1:2025-02 |
| 8 | Ireland exports to United States | 3002 Human blood | EUR 1.0 billion | EUR 1.5 billion 2025-02 | −EUR 542.9 million | −35.1% | DS-045409:IE:US:3002:2:2026-02 DS-045409:IE:US:3002:2:2025-02 |
| 9 | Slovenia imports from Switzerland | 3004 Medicaments | EUR 420.0 million | EUR 953.1 million 2025-02 | −EUR 533.0 million | −55.9% | DS-045409:SI:CH:3004:1:2026-02 DS-045409:SI:CH:3004:1:2025-02 |
| 10 | Germany exports to United States | 3002 Human blood | EUR 1.4 billion | EUR 1.9 billion 2025-02 | −EUR 486.6 million | −25.2% | DS-045409:DE:US:3002:2:2026-02 DS-045409:DE:US:3002:2:2025-02 |
| 11 | Italy exports to Switzerland | 3004 Medicaments | EUR 660.8 million | EUR 1.1 billion 2025-02 | −EUR 458.9 million | −41.0% | DS-045409:IT:CH:3004:2:2026-02 DS-045409:IT:CH:3004:2:2025-02 |
| 12 | Italy exports to United States | 3002 Human blood | EUR 726.9 million | EUR 342.0 million 2025-02 | +EUR 384.9 million | +112.6% | DS-045409:IT:US:3002:2:2026-02 DS-045409:IT:US:3002:2:2025-02 |
| 13 | Italy exports to Ireland | 3004 Medicaments | EUR 426.1 million | EUR 64.7 million 2025-02 | +EUR 361.4 million | +558.7% | DS-045409:IT:IE:3004:2:2026-02 DS-045409:IT:IE:3004:2:2025-02 |
| 14 | Ireland exports to United States | 3003 Medicaments | EUR 345.6 million | EUR 598,433 2025-02 | +EUR 345.0 million | small base | DS-045409:IE:US:3003:2:2026-02 DS-045409:IE:US:3003:2:2025-02 |
| 15 | Netherlands exports to United States | 3004 Medicaments | EUR 50.0 million | EUR 354.5 million 2025-02 | −EUR 304.5 million | −85.9% | DS-045409:NL:US:3004:2:2026-02 DS-045409:NL:US:3004:2:2025-02 |
Largest year on year changes, percent
| # | Flow | Product | February 2026 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Denmark exports to Netherlands | 3002 Human blood | EUR 566.6 million | EUR 3.6 million 2025-02 | +EUR 563.0 million | +15,601.2% | DS-045409:DK:NL:3002:2:2026-02 DS-045409:DK:NL:3002:2:2025-02 |
| 2 | Italy imports from China | 3004 Medicaments | EUR 655.8 million | EUR 5.7 million 2025-02 | +EUR 650.0 million | +11,332.3% | DS-045409:IT:CN:3004:1:2026-02 DS-045409:IT:CN:3004:1:2025-02 |
| 3 | Netherlands imports from Denmark | 3002 Human blood | EUR 553.1 million | EUR 8.4 million 2025-02 | +EUR 544.7 million | +6,512.6% | DS-045409:NL:DK:3002:1:2026-02 DS-045409:NL:DK:3002:1:2025-02 |
| 4 | Italy exports to India | 3004 Medicaments | EUR 92.7 million | EUR 2.0 million 2025-02 | +EUR 90.7 million | +4,542.4% | DS-045409:IT:IN:3004:2:2026-02 DS-045409:IT:IN:3004:2:2025-02 |
| 5 | Ireland imports from Italy | 3004 Medicaments | EUR 587.3 million | EUR 21.5 million 2025-02 | +EUR 565.8 million | +2,633.1% | DS-045409:IE:IT:3004:1:2026-02 DS-045409:IE:IT:3004:1:2025-02 |
| 6 | Denmark exports to Sweden | 3004 Medicaments | EUR 68.7 million | EUR 3.7 million 2025-02 | +EUR 65.0 million | +1,766.6% | DS-045409:DK:SE:3004:2:2026-02 DS-045409:DK:SE:3004:2:2025-02 |
| 7 | Denmark exports to Finland | 3004 Medicaments | EUR 19.3 million | EUR 1.4 million 2025-02 | +EUR 17.9 million | +1,263.4% | DS-045409:DK:FI:3004:2:2026-02 DS-045409:DK:FI:3004:2:2025-02 |
| 8 | Netherlands exports to Japan | 3006 Pharmaceutical goods | EUR 13.1 million | EUR 1.0 million 2025-02 | +EUR 12.1 million | +1,154.4% | DS-045409:NL:JP:3006:2:2026-02 DS-045409:NL:JP:3006:2:2025-02 |
| 9 | Sweden exports to United States | 3002 Human blood | EUR 47.1 million | EUR 3.8 million 2025-02 | +EUR 43.3 million | +1,126.0% | DS-045409:SE:US:3002:2:2026-02 DS-045409:SE:US:3002:2:2025-02 |
| 10 | Belgium exports to Japan | 3002 Human blood | EUR 76.6 million | EUR 6.5 million 2025-02 | +EUR 70.1 million | +1,083.6% | DS-045409:BE:JP:3002:2:2026-02 DS-045409:BE:JP:3002:2:2025-02 |
| 11 | Ireland imports from Sweden | 3002 Human blood | EUR 28.3 million | EUR 2.5 million 2025-02 | +EUR 25.8 million | +1,030.2% | DS-045409:IE:SE:3002:1:2026-02 DS-045409:IE:SE:3002:1:2025-02 |
| 12 | Netherlands exports to Canada | 3002 Human blood | EUR 36.9 million | EUR 3.3 million 2025-02 | +EUR 33.6 million | +1,030.0% | DS-045409:NL:CA:3002:2:2026-02 DS-045409:NL:CA:3002:2:2025-02 |
| 13 | Sweden exports to Italy | 3002 Human blood | EUR 18.2 million | EUR 1.7 million 2025-02 | +EUR 16.5 million | +975.7% | DS-045409:SE:IT:3002:2:2026-02 DS-045409:SE:IT:3002:2:2025-02 |
| 14 | Italy exports to Poland | 3002 Human blood | EUR 101.0 million | EUR 9.6 million 2025-02 | +EUR 91.4 million | +949.0% | DS-045409:IT:PL:3002:2:2026-02 DS-045409:IT:PL:3002:2:2025-02 |
| 15 | Sweden exports to Ireland | 3002 Human blood | EUR 26.2 million | EUR 2.7 million 2025-02 | +EUR 23.5 million | +872.0% | DS-045409:SE:IE:3002:2:2026-02 DS-045409:SE:IE:3002:2:2025-02 |
Data Passport
- Eurostat Comext DS-045409: monthly trade of the EU member states by partner country and product, EUR and net mass, months 2026-01, 2026-02 and 2025-02. Licence: Eurostat reuse policy, free reuse with attribution "Source: Eurostat" (© European Union). Record IDs: DS-045409:reporter:partner:product:flow:month. Source
- Method: For each EU reporter, HS4 product, partner country and flow, the value of February 2026 is compared with the month before and with the same month a year earlier. A missing month row counts as no recorded trade. Lists rank by the absolute change in EUR or by the percent change; aggregates (world, intra and extra EU) and confidential partners are left out, as are Peru and the Philippines.
Trade database built 2026-10-24. Values are official statistics as published; nothing on this page is estimated or invented. More in our methodology.
See the companies
Members see the importers and exporters behind these flows, with their evidence and Data Passport.